Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (81)
- Legislation (15)
- Committees and advisory bodies (12)
- Labelling and packaging (7)
- Manufacturing (7)
- Safety monitoring and information (5)
- Advertising (3)
- Fees and payments (3)
- Import and export (3)
- Sunscreens (3)
- Medicinal cannabis hub (2)
- Shortages and supply disruptions (2)
- Clinical trials (1)
- Compliance and enforcement (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Use the filters or search function to help find relevant consultations.
Search
266 result(s) found, displaying 51 to 75
-
ConsultationThe TGA is seeking feedback on proposed clarification and updates to the regulation of sunscreens. Closing date: 31 May 2023
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 17 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2023-24 financial year. Closing date: 20 March 2023
-
ConsultationThe TGA is seeking feedback on improvements to the therapeutic goods recalls process. Closing 13 March 2023.
-
ConsultationThis consultation is for the interim decision in relation to paracetamol which was discussed at the November 2022 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThis consultation is for interim decisions made in relation to the other substances that were discussed at the November 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 3 February 2023
-
ConsultationThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products (NVPs) in Australia.
-
ConsultationThe TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.
-
ConsultationThis consultation is for interim decisions made in relation to Psilocybine and MDMA proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationWe sought feedback on the draft guidance ‘Boundary and combination products - medicines, medical devices, and biologicals’. Read about the outcome of this consultation.
-
ConsultationThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted.
-
ConsultationThe TGA is considering regulatory options to allow advertisers, including product sponsors, to make references to the TGA in advertising (including on product labels).
-
ConsultationClosing date: 14 October 2022
-
ConsultationThe TGA is seeking feedback on the third consultation paper published by the TGA relating to the Australian implementation of a Unique Device Identification (UDI) System for medical devices.
-
ConsultationPublic consultation on the Product Information (PI) as a package insert in boxed injectable products.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 29 September 2022
-
ConsultationThe (TGA) is seeking feedback on proposed regulatory changes to strengthen safety oversight of clinical trials for medical devices.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 15-16th March 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationClosed: 15 September 2022. Consultation results are now available on the TGA Consultation Hub